Source link : https://www.newshealth.biz/health-news/infrequent-zoledronate-infusions-reduced-vertebral-fractures-soon-after-menopause/
Intravenous zoledronate (Reclast) administered once every 5 years reduced the incidence of morphometric vertebral fractures in early postmenopausal women, a randomized trial showed. Over 10 years of follow-up, a new morphometric vertebral fracture occurred in 6.3% of women who received zoledronate at baseline and at 5 years, in 6.6% of those who received zoledronate at […]
Author : News Health
Publish date : 2025-01-15 22:11:38
Copyright for syndicated content belongs to the linked Source.
inHealth